All news

Knight Therapeutics lifts 2026 revenue guide to C$560-570 million as Q3 sales rise 13%

GlobeNewswire · · AI-summarised by FinFlash

Montreal-based Knight Therapeutics reported third-quarter revenue of C

So What?

Higher guidance and net cash of C

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.